Extended-release carbamazepine

DRUG3 trials

Sponsors

Validus Pharmaceuticals

Conditions

Bipolar DisorderBipolar I Disorder

Phase 3

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

CompletedNCT00150605

Validus PharmaceuticalsBipolar Disorder

Start: 2005-02-28End: 2005-10-31Target: 50Updated: 2007-11-02

Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder

CompletedNCT00150553

Validus PharmaceuticalsBipolar Disorder

Start: 2005-01-31End: 2005-10-31Target: 102Updated: 2007-11-02

Phase 4

The Young Adult and Pediatric Bipolar Study

CompletedNCT00350857

Validus PharmaceuticalsBipolar I Disorder

Start: 2006-07-31End: 2007-10-31Updated: 2014-02-20